COVID-19 vaccine study shows severe disease preventable in hamsters
On Sept. 3, 2020, Oregon Health & Science University (OHSU) announced that for the first time, early research…
On Sept. 3, 2020, Oregon Health & Science University (OHSU) announced that for the first time, early research…
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ᄋRNA (OR-100) collection device was included along with other…
On Sept. 3, 2020, a team of Virginia Tech researchers announced that they will begin testing wastewater at…
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
On Sept. 2, 2020, Mesoblast announced that it had received ethics approval to include Australian hospitals in the…
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
On Sept. 2, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that it had made a…
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
On Sept. 2, 2020, UT Southwestern announced that it had performed the first HIV-positive-to-HIV-positive organ transplant in Texas….
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
On Sept. 1, 2020, Amyris announced that it had successfully scaled up the commercial production of Cannabigerol (CBG)…
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
On Aug. 31, 2020, in a study published in PNAS, researchers used conservation biology and genomics to discover…
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…